EU Clears NewAmsterdam's Cholesterol Pills in First Global Approval
European regulators approved NewAmsterdam Pharma's Ubeslo and Evlarco, its first global nods. Menarini will sell both in Europe, paying tiered royalties up to the mid-20% range on net sales.